ASIA PACIFIC CRISPR MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • ASIA PACIFIC CRISPR MARKET FORECAST 2019-2027

ASIA PACIFIC CRISPR MARKET FORECAST 2019-2027

The Asia-Pacific CRISPR market is expected to exhibit a 33.84% CAGR over the forecast period of 2019-2027. The growth rate for the progress of this market is expected to be more significant as compared to other regional markets. CRISPR market majorly finds its applications in areas like agriculture and animal breeding in the Asia-Pacific countries of Japan, China, India, and South Korea.

ASIA PACIFIC CRISPR MARKET FORECAST 2019-2027

Asia Pacific CRISPR Market by Product (Design Tools Product, Plasmids and Vectors Product, CAS9 Nuclease and GRNA Product, Delivery System Product) by End User (Biotechnology Companies, Pharmaceutical Companies, Academic Institutes, Research and Development Institutes) by Geography

Request free sample

The Asia-Pacific CRISPR market is expected to exhibit a 33.84% CAGR over the forecast period of 2019-2027. The growth rate for the progress of this market is expected to be more significant as compared to other regional markets.

CRISPR market majorly finds its applications in areas like agriculture and animal breeding in the Asia-Pacific countries of Japan, China, India, and South Korea. Factors like rising elderly population and changing lifestyle are leading to several chronic disorders amongst the APAC population, including diabetes, cancer, hypertension, etc. For the Indian market, which accounts for a considerable share for farming and animal breeding, the genetic sequencing of farm animals is expected to have a positive impact on sustainable livestock production. The Chinese market experiences several restrictions for agricultural GMOs, imposed by the State Council and relevant administrative and regulatory bodies. The central government of Japan recently approved the genome editing of rice plants. Although it is legal to plant genetically modified crops in Japan (if proper regulatory procedures are followed); as of yet no commercial planting of genetically modified crops has been done. This is because people are still sceptical about this technology.

Some of the leading market companies in this region are Caribou Biosciences Inc, Intellia Therapeutics Inc, Cellectis Bioresearch Sas, Crispr Therapeutics Ag, Integrated DNA Technologies (IDT), Genscript, Editas Medicine, Novartis International Ag, Transposagen Biopharmaceuticals Inc, Sigma-Aldrich (Merck), Thermo Fisher Scientific, and Precision Biosciences.

 

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

 

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • PLASMIDS HOLD THE LARGEST MARKET SHARE IN TERMS OF PRODUCTS
      • INDUSTRIAL BIOTECH IS THE FASTEST GROWING END USER
      • GENOME EDITING/ GENETIC ENGINEERING IS MAJORLY USED APPLICATION
  1. MARKET DETERMINANTS
    • MARKET DRIVERS
      • INCREASING DEMAND FOR DRUG DISCOVERY
      • LATE PREGNANCIES LEADING TO BIRTH DISORDERS
      • RISK OF CONGENITAL ANAMOLITIES
      • AGING GERIATRIC POPULATION
      • INVESTMENT IN PATH BREAKING RESEARCH TECHNOLOGY
      • CHANGING LIFESTYLES
      • PREVALENCE OF GENETIC DISORDERS
      • INCREASING GENETIC DISEASES
      • GROWING AWARENESS REGARDING GENE THERAPEUTICS
    • MARKET RESTRAINTS
      • POSSIBLE MISUSE OF CRISPR GENE EDITING TOOL
      • LACK OF AWARENESS
      • LACK OF HEALTHCARE BUDGETS IN DEVELOPING COUNTRIES
    • MARKET OPPORTUNITIES
      • GENOME SURGERY TO REWRITE GENETIC DISORDERS
      • CLINICAL TRIALS IN ASIA
      • GROWING USAGES OF POTENTIAL APPLICATIONS OF CRISPR TECHNOLOGY
    • MARKET CHALLENGES
      • PROTECTION OF PATENT
      • ALTERNATE TECHNOLOGIES
      • ETHICAL ISSUES
  1. MARKET BY PRODUCT
    • DESIGN TOOLS
    • PLASMIDS
    • VECTORS
    • LIBRARY
    • CONTROL KITS
    • PROTEINS
    • GRNA
    • OTHER PRODUCTS
  2. MARKET BY END USER
    • BIOLOGICAL RESEARCH
    • AGRICULTURAL BIOTECH
    • INDUSTRIAL BIOTECH
    • THERAPEUTICS AND DRUG DISCOVERY
  3. MARKET BY APPLICATION
    • GENOME EDITING/ GENETIC ENGINEERING
    • GRNA DATABASE/GENE LIBRARY
    • CRISPR PLASMID
    • HUMAN STEM CELLS
    • CELL LINE ENGINEERING
  4. KEY ANALYTICS
    • PORTER’S 5 FORCE MODEL
      • THREATS OF NEW ENTRANTS
      • THREAT OF SUBSTITUTES
      • BARGAINING POWER OF BUYER
      • BARGAINING POWER OF SUPPLIER
      • INTENSITY OF COMPETITIVE RIVALRY
    • MARKET ETYMOLOGY
    • SUPPLY CHAIN ANALYSIS
    • REGULATORY FRAMEWORK
    • REGULATORY BODIES
    • VALUE CHAIN ANALYSIS
    • KEY BUYING CRITERIA
    • STRATEGIC RECOMMENDATION AND CONCLUSION
    • PIPELINE ANALYSIS
  5. GEOGRAPHICAL ANALYSIS
    • ASIA PACIFIC (APAC)
      • INDIA
      • CHINA
      • JAPAN
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF APAC
  1. COMPETITIVE ANALYSIS
    • MARKET SHARE ANALYSIS
    • COMPANY PROFILE
      • ADDGENE
      • APPLIED STEMCELL, INC.
      • CARIBOU BIOSCIENCES INC.
      • CELLECTIS BIORESEARCH SAS
      • CRISPR THERAPEUTICS AG
      • DIACARTA, INC.
      • EDIGENE, INC.
      • EDITAS MEDICINE
      • GENECOPOEIA, INC.
      • GENEDATA AG
      • GENSCRIPT
      • HORIZON DISCOVERY PLC.
      • INTEGRATED DNA TECHNOLOGIES
      • INTELLIA THERAPEUTICS INC
      • LONZA GROUP AG
      • NEW ENGLAND BIOLABS INC
      • NOVARTIS INTERNATIONAL AG
      • ORIGENE TECHNOLOGIES INC
      • PRECISION BIOSCIENCES
      • SANGAMO THERAPEUTICS
      • SIGMA-ALDRICH (MERCK)
      • THERMO FISHER SCIENTIFIC
      • TRANSPOSAGEN BIOPHARMACEUTICALS INC.

LIST OF TABLES

TABLE 1       ASIA PACIFIC CRISPR MARKET 2019-2027($ MILLIONS)

TABLE 2       VARIOUS INITIATIVES AND POLICIES UNDERTAKEN BY THE GOVERNMENT IN HEALTHCARE SECTOR

TABLE 3       RISING PUBLIC HEALTH AND LONG-TERM CARE EXPENDITURE OVER THE NEXT DECADES (%)

TABLE 4       MAJOR CONCERNS RELATED WITH GENETIC ENGINEERING

TABLE 5       ASIA PACIFIC CRISPR MARKET BY PRODUCT 2019-2027 ($ MILLIONS)

TABLE 6       TOOLS NAME AND THEIR PROVIDERS

TABLE 7       ASIA PACIFIC DESIGN TOOLS MARKET 2019-2027 ($ MILLIONS)

TABLE 8       ASIA PACIFIC PLASMIDS MARKET 2019-2027 ($ MILLIONS)

TABLE 9       ASIA PACIFIC VECTORS MARKET 2019-2027 ($ MILLIONS)

TABLE 10     ASIA PACIFIC LIBRARY MARKET 2019-2027 ($ MILLIONS)

TABLE 11     ASIA PACIFIC CONTROL KITS MARKET 2019-2027 ($ MILLIONS)

TABLE 12     ASIA PACIFIC PROTEINS MARKET 2019-2027 ($ MILLIONS)

TABLE 13     ASIA PACIFIC GRNA MARKET 2019-2027 ($ MILLIONS)

TABLE 14     ASIA PACIFIC OTHER PRODUCTS MARKET 2019-2027 ($ MILLIONS)

TABLE 15     ASIA PACIFIC CRISPR MARKET BY END USER 2019-2027 ($ MILLIONS)

TABLE 16     ASIA PACIFIC BIOLOGICAL RESEARCH MARKET 2019-2027 ($ MILLION)

TABLE 17     ASIA PACIFIC AGRICULTURAL BIOTECH MARKET 2019-2027 ($ MILLION)

TABLE 18     ASIA PACIFIC INDUSTRIAL BIOTECH MARKET 2019-2027 ($ MILLION)

TABLE 19     ASIA PACIFIC THERAPEUTICS AND DRUG DISCOVERY MARKET 2019-2027 ($ MILLION)

TABLE 20     ASIA PACIFIC CRISPR MARKE BY APPLICATION 2019-2027 ($ MILLIONS)

TABLE 21     ASIA PACIFIC GENOME EDITING/ GENETIC ENGINEERING MARKET 2019-2027 ($ MILLIONS)

TABLE 22     BARRIERS TO ENTRY IN THE AGRICULTURAL SEED MARKET

TABLE 23     TRAITS AND TECHNOLOGY HISTORY OF PLANT BIOTECH

TABLE 24     AGRICULTURE BIOTECH TRAITS INDUSTRY

TABLE 25     COMPANY RELATED TO AGRICULTURE BIOTECHNOLOGY INVOLVED IN GENOME EDITING TOOL CRISPR

TABLE 26     AGRICULTURAL BIOTECHNOLOGY COMPANY LICENSING CRISPR PRODUCTS

TABLE 27     KEY COMPETITORS IN THE AGRICULTURAL BIOLOGICALS INDUSTRY

TABLE 28     ASIA PACIFIC GRNA DATABASE/GENE LIBRARY MARKET 2019-2027 ($ MILLIONS)

TABLE 29     ASIA PACIFIC CRISPR PLASMID MARKET 2019-2027 ($ MILLIONS)

TABLE 30     ASIA PACIFIC HUMAN STEM CELLS MARKET 2019-2027 ($ MILLIONS)

TABLE 31     ASIA PACIFIC CELL LINE ENGINEERING MARKET 2019-2027 ($ MILLIONS)

TABLE 32     ASIA PACIFIC CRISPR MARKET BY COUNTRY 2019-2027 ($ MILLIONS)

LIST OF FIGURES

FIGURE 1     FATALITIES INCREASING DUE TO LIFESTYLE ORIENTED DISEASES (IN THOUSAND)

FIGURE 2     REASON FOR OUTSOURCING DRUG DISCOVERY PROJECTS

FIGURE 3     ASIA PACIFIC CRISPR MARKET BY DESIGN TOOLS 2019-2027 ($ MILLIONS)

FIGURE 4     ASIA PACIFIC CRISPR MARKET BY PLASMIDS 2019-2027 ($ MILLIONS)

FIGURE 5     ASIA PACIFIC CRISPR MARKET BY VECTORS 2019-2027 ($ MILLIONS)

FIGURE 6     ASIA PACIFIC CRISPR MARKET BY LIBRARY 2019-2027 ($ MILLIONS)

FIGURE 7     ASIA PACIFIC CRISPR MARKET BY CONTROL KITS 2019-2027 ($ MILLIONS)

FIGURE 8     ASIA PACIFIC CRISPR MARKET BY PROTEINS 2019-2027 ($ MILLIONS)

FIGURE 9     ASIA PACIFIC CRISPR MARKET BY GRNA 2019-2027 ($ MILLIONS)

FIGURE 10   ASIA PACIFIC CRISPR MARKET BY OTHER PRODUCTS 2019-2027 ($ MILLIONS)

FIGURE 11   ASIA PACIFIC CRISPR MARKET BY BIOLOGICAL RESEARCH 2019-2027 ($ MILLION)

FIGURE 12   ASIA PACIFIC CRISPR MARKET BY AGRICULTURAL BIOTECH 2019-2027 ($ MILLION)

FIGURE 13   ASIA PACIFIC CRISPR MARKET BY INDUSTRIAL BIOTECH2019-2027 ($ MILLION)

FIGURE 14   ASIA PACIFIC CRISPR MARKET BY THERAPEUTICS AND DRUG DISCOVERY 2019-2027 ($ MILLION)

FIGURE 15   ASIA PACIFIC CRISPR MARKET BY GENOME EDITING/ GENETIC ENGINEERING 2019-2027 ($ MILLIONS)

FIGURE 16   ASIA PACIFIC CRISPR MARKET BY GRNA DATABASE/GENE LIBRARY 2019-2027 ($ MILLIONS)

FIGURE 17   ASIA PACIFIC CRISPR MARKET BY CRISPR PLASMID 2019-2027 ($ MILLIONS)

FIGURE 18   ASIA PACIFIC CRISPR MARKET BY HUMAN STEM CELLS 2019-2027 ($ MILLIONS)

FIGURE 19   ASIA PACIFIC CRISPR MARKET BY CELL LINE ENGINEERING 2019-2027 ($ MILLIONS)

FIGURE 20   VALUE CHAIN ANALYSIS

FIGURE 21   INDIA CRISPR MARKET 2019-2027 ($ MILLION)

FIGURE 22   CHINA CRISPR MARKET 2019-2027 ($ MILLION)

FIGURE 23   JAPAN CRISPR MARKET 2019-2027 ($ MILLION)

FIGURE 24   SOUTH KOREA CRISPR MARKET 2019-2027 ($ MILLION)

FIGURE 25   AUSTRALIA CRISPR MARKET 2019-2027 ($ MILLION)

FIGURE 26   REST OF APAC CRISPR MARKET 2019-2027 ($ MILLION)

FIGURE 27   CRISPR MARKET COMPANIES SHARE 2017 (%)

  1. GEOGRAPHICAL ANALYSIS
    • ASIA PACIFIC (APAC)
      • INDIA
      • CHINA
      • JAPAN
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF APAC
  1. MARKET BY PRODUCT
    • DESIGN TOOLS
    • PLASMIDS
    • VECTORS
    • LIBRARY
    • CONTROL KITS
    • PROTEINS
    • GRNA
    • OTHER PRODUCTS
  2. MARKET BY END USER
    • BIOLOGICAL RESEARCH
    • AGRICULTURAL BIOTECH
    • INDUSTRIAL BIOTECH
    • THERAPEUTICS AND DRUG DISCOVERY
  3. MARKET BY APPLICATION
    • GENOME EDITING/ GENETIC ENGINEERING
    • GRNA DATABASE/GENE LIBRARY
    • CRISPR PLASMID
    • HUMAN STEM CELLS
    • CELL LINE ENGINEERING

 

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now